Company News in the Life Science Industry

CHAPEL HILL, N.C., Jan. 18, 2019 /PRNewswire/ -- The pharma industry recognizes the potential value of attacking complex diseases such as cancer through new therapies that utilize combinations of FDA-approved products.

WEST ORANGE, N.J., Jan. 18, 2019 /PRNewswire/ -- Healthy Aging Medical Centers is pleased to announce it now... Read more ››

INDIANAPOLIS, Jan. 18, 2019 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced that results from the global Phase 3 REACH-2 study of CYRAMZA(®) (ramucirumab) as a single agent in the second-line treatment of people with AFP-High (alpha-fetoprotein >=400 ng/mL) hepatocellular carcinoma... Read more ››